According to Prelude Therapeutics's latest financial reports the company's current revenue (TTM ) is โน1.60 Billion. In 2025 the company made a revenue of โน1.08 Billion an increase over the revenue in the year 2024 that were of โน0.60 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.